India Coronavirus Vaccine Candidate From Cadila Healthcare • MV TELEGRAPH : vimarsana.com

SINGAPORE - Indian drug maker Cadila Healthcare is about to start a phase 3 clinical trial for a potential coronavirus vaccine, its chairman told CNBC.

Related Keywords

India , New Delhi , Delhi , Singapore , Bharat , Pankaj Patel , Zydus Cadila , Indira Gandhi International Airport , Johns Hopkins University , Oxford University , Astrazeneca , Indian State Council For Local Medical Research , India Medicines Agency , Serum Institute Of India , Indian Medicines Agency On , Cadila Healthcare , Medicines Agency , Freight Terminal , Indian Medicines Agency , Serum Institute , Bharat Biotech , Indian State Council , Local Medical Research ,